Elan (ELN) Will Be a Buyer Not a Seller, Unless Offer Nears $20/Sh - Jefferies
Tweet Send to a Friend
Jefferies commented on Elan Corp (NYSE: ELN) following yesterday's $11/share bid from Royalty Pharma. The firm said while it ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
